Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of MH002 in Acute Pouchitis
2021-006656-14Phase 2Completed
- Sponsor
- MRM Health
- Start
- Apr 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of MH002 in pouchitis, sponsored by MRM Health. Primary endpoint: Safety (treatment-emergent AEs and ARs). Started Apr 2022; status: completed.
02
Drugs
MH002
03
Conditions
pouchitis
Beyond the preview
Go deeper on 2021-006656-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006656-14.